Coexistence of Hereditary Transthyretin Amyloid Cardiomyopathy and Sarcomeric Hypertrophic Cardiomyopathy: A Multimodality Imaging and Genetic Case Report

Clicks: 1
ID: 320437
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #63 of 248 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 248 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Structured Abstract Background Unexplained left ventricular hypertrophy (LVH) represents a diagnostic challenge, as phenotypic overlap may exist between sarcomeric hypertrophic cardiomyopathy (HCM) and infiltrative cardiomyopathies such as transthyretin amyloid cardiomyopathy (ATTR-CM). Multimodality imaging and genetic testing are crucial when standard findings are discordant. Case Summary A 78-year-old woman presented with exertional dyspnoea (NYHA class II) and asymmetric septal hypertrophy without secondary causes. Transthoracic echocardiography showed preserved left ventricular ejection fraction with reduced basal longitudinal strain and relative apical sparing. Cardiac magnetic resonance demonstrated elevated native T1 values (1240–1270 ms), mildly increased T2 values, and basal ring-like late gadolinium enhancement. Bone scintigraphy revealed Perugini grade 3 myocardial uptake, consistent with ATTR-CM. Monoclonal gammopathy was excluded. Genetic testing identified a pathogenic transthyretin mutation (TTR p.Ile88Leu) and a concomitant likely pathogenic sarcomeric MYH7 variant (p.Gly733Arg). Neurological assessment was unremarkable. The overall phenotype was dominated by amyloid infiltration. Following multidisciplinary evaluation, the patient was started on tafamidis 61 mg once daily. Cascade genetic and clinical screening was recommended for first-degree relatives.
Reference Key
openalex_W7167922352 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Francesco Negri, Mauro Driussi, Michela Puppato, Lorenzo Zuliani, Massimo Imazio
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag515
URL
https://doi.org/10.1093/ehjcr/ytag515
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.